Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker

Published:2010-08-18 Issue:8 Volume:5 Page:e12226
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Firneisz Gábor,Varga Tímea,Lengyel Gabriella,Fehér János,Ghyczy Dóra,Wichmann Barna,Selmeci László,Tulassay Zsolt,Rácz Károly,Somogyi Anikó

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference23 articles.

1. Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study.;GN Ioannou;Gastroenterology,2003

2. Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.;R de Marco;Diabetes Care,1999

3. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.;AJ Hanley;Diabetes Care,2007

4. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis.;A Fraser;Diabetes Care,2009

5. Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action.;DJ Drucker;Diabetes Care,2007

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the impact of metabolic dysfunction–associated steatotic liver disease on drug transport and metabolism?;Expert Opinion on Drug Metabolism & Toxicology;2024-03-03

2. Glycaemic control efficacy of switching from dipeptidyl peptidase‐4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 2 study);Diabetes, Obesity and Metabolism;2023-12-11

3. Visualizing Dipeptidyl Peptidase-IV with an Advanced Non-π-Conjugated Fluorescent Probe for Early Thyroid Disease Diagnosis;Analytical Chemistry;2023-11-21

4. Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study;Life;2023-06-05

5. Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration;Seminars in Liver Disease;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3